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Abstract We previously established a novel mouse model for
human aging and identified the genetic foundation responsible for
it. A defect in expression of a novel gene, termed klotho (kl),
leads to a syndrome resembling human aging in mice. The kl gene
encodes a single-pass membrane protein whose extracellular
domain carries homology to L-glucosidases. In this report, we
present the entire mouse kl gene organization. The mouse kl gene
spans about 50 kilobases and consists of five exons. The
promoter region lacks a TATA-box and contains four potential
binding sites for SP1. We further show that two kl gene
transcripts encoding membrane or secreted protein are generated
through alternative transcriptional termination. These findings
provide fundamental information for further study of the kl gene
which may regulate aging in vivo.
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1. Introduction
Recently, we have identi¢ed a novel gene, termed klotho
(kl), that is involved in the development of a syndrome resem-
bling human aging in mice [1]. A defect in kl gene expression
in mice leads to multiple disorders including arteriosclerosis,
osteoporosis, pulmonary emphysema and skin atrophy to-
gether with short life-span and infertility. The kl gene encodes
a novel single-pass membrane protein of 1014 amino acids,
whose extracellular domain consists of two-fold internal re-
peats with homology to L-glucosidases [2,3]. The kl gene tran-
script was not detected in many organs, including the stom-
ach, lung, submandibular gland, skin and bone, where severe
changes occurred in the mutants. To explain these apparently
cell non-autonomous phenomena, it must be assumed that a
secreted circulating factor mediates the pleiotropic functions
of the Klotho (KL) protein, at least in part [1].
In this article, we report the structure of the mouse kl gene
and its promoter region and the identi¢cation of a novel var-
iant of kl gene transcript that encodes a putative secreted form
of KL protein. The discovery of a secreted form of kl gene
product may provide important information for understand-
ing the molecular function of the kl gene and the molecular
mechanisms of human aging and aging related disorders.
2. Materials and methods
2.1. Isolation of the mouse kl gene
A bacterial arti¢cial chromosome (BAC) library (Research Genetics
Inc., Huntsville, AL) was screened by PCR using the primer pair 5P-
AGGCTCATCAGAGGAACTGC-3P and 5P-AAGACAGAAGCT-
GCCTCAGG-3P speci¢c for mouse kl cDNA. The positive BAC
clones were partially digested with Sau3AI and subcloned into the
cosmid vector pWE15 (Clontech) at the BamHI site to construct a
cosmid contig of the mouse kl locus. Intron size was determined by
sequencing or estimated by PCR using primers speci¢c for the £ank-
ing exons. Sequencing was performed using the cycle sequencing
method with SequiTherm EXCEL II DNA Polymerase (SequiTherm
EXCEL Long-Read DNA Sequencing Kits-LC, Epicentre Technolo-
gies) in a LI-COR Model 4000L Automated DNA Sequencer accord-
ing to the manufacturer’s instructions. Sequence data were analyzed
using GeneWorks software (Oxford Molecular Group, Inc.).
2.2. Determination of transcription start sites
An S1 nuclease protection assay was performed using an S1 map-
ping kit (Ambion) according to the supplier’s protocol. A 395 bp
genomic DNA fragment containing a putative transcription initiation
site was synthesized by PCR using the primer pair 5P-CC-
TGCTGTGCTCTCTCTGGG-3P and 5P-AAACCGTCGGGGAA-
GGTGT-3P. The fragment was 5P end-labeled using the Megalabel
Kit (TaKaRa). The labeled DNA was strand separated and the anti-
sense strand was hybridized with 6 Wg mouse kidney poly(A) RNA
at 42‡C for 16 h, then digested with 500 U S1 nuclease at 37‡C for
30 min. The protected fragments were analyzed by electrophoresis on
a 5% acrylamide/8 M urea gel.
2.3. RT-PCR
Poly(A) RNA (500 ng) from various organs was reverse tran-
scribed with random hexamer (TaKaRa), and 5% of the reaction
mixture was ampli¢ed by LA-Taq DNA polymerase (TaKaRa) using
a primer pair speci¢c for the mouse secreted isoform (INS-2 (Fig. 3):
5P-GGGTTTTGTCAAAGGACTTAC-3P and mEX6: 5P-AGGCT-
CATCAGAGGAACTGC-3P in exon 2 of the kl gene). The condition
for ampli¢cation was 30 cycles of 94‡C for 20 s, 60‡C for 30 s, 72‡C
for 60 s.
2.4. 3P RACE-PCR and 5P RACE-PCR
A clone containing the 3P untranslated region of the mouse secreted
isoform was generated by the rapid ampli¢cation of cDNA end meth-
od using the Mouse Kidney Marathon-Ready cDNA kit (Clontech)
[4,5]. For the primary PCR reaction, the adaptor primer-1 (AP1)
provided in the kit and the forward primer INS-5U (Fig. 3) (5P-GA-
CAAAACCCAGTGTCGGCCTC-3P) were used. For the secondary
PCR, the adaptor primer-2 (AP-2 nested to AP-1) provided in the kit
and the forward primer INS-6U (Fig. 3) (5P-CACTAAGCTCTGGC-
CAAGGCAC-3P) were used. Using the same kit, the 5P end of a
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mouse secreted isoform cDNA was ampli¢ed. The ¢rst PCR was
performed using AP-1 and INS-1 (Fig. 3) (5P-TTAGTGAGGAAG-
CAAGAGGCC-3P). The secondary PCR was performed using AP-2
and INS-2. The secondary PCR product was directly cloned into the
pCR2.1 vector (Invitrogen) and sequenced.
2.5. Competitive PCR
Speci¢c competitors of the membrane or secreted isoform were
obtained using PCR MIMIC Construction Kit (Clontech). Poly(A)
RNA (500 ng) from various tissues was reverse transcribed with ran-
dom hexamer (TaKaRa), and 5% (v/v) of the reaction mixture and
competitor was ampli¢ed by EX-Taq DNA polymerase (TaKaRa).
The conditions for PCR were 25 cycles of 94‡C for 20 s, 60‡C for
30 s and 72‡C for 1 min. PCR products were analyzed by 1.5%
agarose gel electrophoresis. In the competitive PCR of the secreted
form transcripts, the 549 bp and 321 bp PCR products represent the
secreted isoform and its competitor, when the same primer set for RT-
PCR was used. In the PCR of the membrane isoform transcripts, the
597 bp and 323 bp PCR products represent the membrane form and
its competitor, when mEX8R (5P-CCTCTTACTGTGATGCACA-
TCC-3P in exon 4 of the kl gene) instead of the INS-2 primer was
used. A photograph of the illuminated gel (Polaroid 667 ¢lm) was
scanned using PDI-Quantity One (Toyobo). The amount of mouse
kl mRNA was calculated following the procedure of the PCR MIMIC
Construction Kit (Clontech) [6^8].
3. Results
A total of ¢ve independent BAC clones were isolated by
PCR screening of a mouse BAC genomic library [9]. These
clones harbored approximately 100 kbp inserts estimated by
pulse-¢eld gel electrophoresis (data not shown). Sequence
analysis of the BAC clones revealed that the mouse kl gene
spans about 50 kbp and consists of ¢ve exons (Fig. 1). Exon-
intron junctions and the distance between exons are shown in
Table 1. S1-nuclease mapping analysis revealed the existence
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Fig. 1. Structure of the mouse kl gene and its two gene transcripts. Open boxes represent exons and the thick line represents introns. A: The
transcript encoding the membrane protein is 5.2 kbp mRNA and contains ¢ve exons. B: The transcript encoding the secreted protein is 5.8
kbp mRNA and contains three exons. The gray box represents the continuation of exon 3 in the secreted isoform. The translation start codon
and the termination codon are shown above the transmembrane form and under the secreted form transcripts, respectively.
Table 1
Exon/intron characteristics of the mouse kl gene
Exon 3P Splice site 5P Splice site Exon size Intron size
838
1 CTA CTT TTG gttgagttcga 838 bp s 33 kbp
L L L
839 1349
2 tcctctgtag GCT CAT GCC T ACC TTA AAA G gtaggctttc 511 bp 1372 bp
A H A T L K
1350 1618
3 ccctctgcag CA ATC AHA T TAC GTT CAA gtaagtcctt 269 bp 5604 bp
A I R Y V Q
1619 2720
4 ttctttgtag GTG GAC ACT T GCT CTG AAA G gtgagacccc 1102 bp s 1.8 kbp
V D T A L K
2721
5 ttttctctag CC TAC GTG 2299 bp
A Y V
Exon and intron sequences are indicated by uppercase and lowercase letters, respectively. Amino acids are indicated by bold letters. Nucleotide
position is assigned starting from the major transcription start site. The gt-ag (5PC3P) rule of the splice site is conserved. Intron size was determined
by direct sequencing (intron 2 and 3) or estimated by PCR.
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of two transcription start sites. The major start site is mapped
to 13 bp upstream of the translation start (ATG) and the
minor start site to 23 bp upstream. In the 5P £anking region
up to 540 bp upstream from the major transcription start site,
there are neither TATA-like consensus sequences nor CAAT
cis-acting elements; there are, however, four putative SP1
binding sites (Fig. 2) [10]. In the human kl gene, we have
found that alternative splicing at an internal splice donor
site in exon 3 results in two splice variants, which encode
either a membrane or a secreted form of KL protein [11]. In
order to determine whether there are similar splice variants in
mice, we examined mouse kidney cDNA using primers speci¢c
for mouse genomic sequences in the vicinity of exon 2, exon 3
or exon 4. As a result, a second type transcript encoding the
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Fig. 2. Promoter region of the mouse kl gene. The nucleotide sequence of the exon is indicated by bold letters. The 5P untranslated sequence is
indicated by uppercase letters. The two transcription start sites are indicated by asterisks, and the major transcription start site is designated
+1. Four putative SP1 binding sites are underlined.
Fig. 3. Partial cDNA sequence of the secreted isoform of the mouse kl gene. The predicted amino acid sequence is shown beneath the cDNA
sequence in single letter code. The termination codon is indicated by an asterisk. Translated sequences speci¢c for the secreted isoform are indi-
cated by bold letters. The primer sites used for the 3P RACE and 5P RACE analysis are indicated by dotted lines and underlines, respectively.
The putative polyadenylation signal is indicated by underlined bold letters.
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secreted form of KL protein was identi¢ed (Fig. 1B). Precur-
sor RNA of the second type transcript initiates from the same
start sites as the membrane form transcript and terminates
about 4.2 kbp downstream of the 3P end of exon 3 of the
membrane form (Fig. 1). The transcriptional termination
site is located near upstream of exon 4 of the membrane
form and thus the splicing acceptor sequence of intron 3 is
excluded from the precursor transcript of the secreted form,
making the long stretch of sequence corresponding to intron 3
of the membrane form to be unspliced from the mature se-
creted form mRNA. As a result, the secreted form of the kl
gene product is 5.8 kbp in length and composed of exons 1, 2
and long exon 3. A polyadenylation signal (AATAAA) is
found near its end (Fig. 3) and an in-frame translation stop
codon (TAA) appeared 49 bp downstream of the 3P end of
exon 3 of the membrane form transcript (Figs. 1 and 3). The
second type of kl transcript encodes a putative secreted pro-
tein of 550 amino acids (corresponding to mKL1 [1]), lacking
the transmembrane domain.
Expression of secreted form mRNA is not detected by
Northern blot analysis, but it is detected by RT-PCR in sev-
eral tissues. As shown in Fig. 4, the secreted form is expressed
in the pituitary gland, ovary, whole brain, brain medulla,
kidney, testis, pancreas and thyroid gland. Expression was
not detected even by RT-PCR in other tissues. The tissue
distribution of the secreted form is similar to that of the
membrane form [1]. Competitive PCR revealed that expres-
sion of the membrane form is about 10 times greater than the
secreted form in the pituitary gland (Fig. 5). In other tissues,
the membrane form always predominates the secreted form by
more than 10 times (data not shown). The ratio of secreted
form transcript to membrane form transcript in various tis-
sues does not signi¢cantly change with age (data not shown).
4. Discussion
In this study, we have determined the structure of the
mouse kl gene and its promoter. The promoter region con-
tains several potential Sp1 binding sites and shows character-
istics of a TATA-less promoter. We further identi¢ed two
transcripts encoding either a membrane or a secreted protein.
These results provide fundamental information for further
investigation of the kl gene. The kl mutation does not disrupt
the coding structure of the kl gene but severely reduces its
expression [1]. The structural analysis of the kl gene revealed
that the insertional mutation in kl/kl mice is located not in the
kl gene but in the 5P £anking region about 6 kbp upstream of
the transcription start site. This may be the reason why the kl
gene is slightly transcribed in the mutants. Since the mutation
is accompanied by a deletion of about 8 kbp, it could be that
cis-acting element(s) with enhancer activity exist within the
deletion.
The transcript of the membrane isoform contains ¢ve
exons, showing the same organization in both mice and hu-
mans [11]. On the other hand, the transcript of the mouse
secreted isoform contains three exons, whereas the transcript
of the human secreted isoform contains ¢ve exons. In addi-
tion, the expression level of the two isoforms is very di¡erent
between mice and humans: the membrane isoform predomi-
nates over the secreted isoform in mice, whereas it is vice
versa in humans. To assume the circulating factor mediating
the functions of Klotho protein, we should assume at least
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Fig. 4. Expression of the secreted isoform of the mouse kl gene. Expression of the secreted isoform of the mouse kl gene was detected by RT-
PCR in various tissues. The (+) lanes show the samples reacting with AMV reverse transcriptase, and (3) lanes are negative controls (no re-
verse transcriptase). The size of the expected fragment (549 bp) is indicated by an arrow. Expression of GAPDH was examined in all tissues
(data not shown). M: 100 bp ladder marker.
Fig. 5. Quantitation of the expression of the two isoforms by RT-
competitive PCR in pituitary gland. The amount of competitor is
10 amol/Wl in lanes 1 and 6, 1.0 amol/Wl in lanes 2 and 7, 1031
amol/Wl in lanes 3 and 8, 1032 amol/Wl in lanes 4 and 9, 1033 amol/
Wl in lanes 5 and 10. Lanes 1^5 contain the secreted isoform, and
lanes 6^10 contain the membrane isoform. Three independent ex-
periments were performed. The secreted isoform expressed 1.9U105
copies/Wg mRNA, and the membrane isoform expressed 1.9U106
copies/Wg mRNA. M: 100 bp ladder marker.
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three possible hypotheses: (1) Klotho protein converts an in-
active precursor to an active humoral factor, (2) Klotho pro-
tein itself is secreted into extracellular spaces and function as a
humoral factor, or (3) Klotho protein works as a receptor and
mediates the signal required for the production of a novel
humoral substance. Further investigation is necessary to de-
termine how KL protein is involved in the suppression of a
syndrome resembling aging.
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